• Yale University researchers have developed an airborne method for delivering mRNA right to your lungs.
• In a study on mice, the scientists created polymer nanoparticles to encapsulate mRNA, making it inhalable.
• Researchers say this "new method of delivery could 'radically change the way people are vaccinated,'" making it easier to vaccinate people in remote areas or those who are afraid of needles.
• An airborne mRNA product could be used to rapidly vaccinate the masses, without their knowledge or consent.
• Academic endorsement exists for the use of compulsory, covert bioenhancements, including drugs and vaccines, on the public; the US government also has a history of covert bioweapon experiments.

Yale University researchers have developed a new airborne method for delivering mRNA right to your lungs. The team has also used the method to vaccinate mice intranasally, opening the door for human testing in the near future.

While scientists are hailing the creation as an easy way to vaccinate the masses, critics wonder if the development of an airborne vaccine could be used for nefarious purposes, including covert bioenhancements, which have already been recommended in academic literature.

Yale team develops airborne mRNA, delivers it to lungs

In a study on mice, Yale scientists created polymer nanoparticles to encapsulate mRNA, making it inhalable so it can reach the lungs. Courtney Malo, editor with Science Translational Medicine, which published the study, explained:

The ability to efficiently deliver mRNA to the lung would have applications for vaccine development, gene therapy, and more. Here, Suberi et al. showed that such mRNA delivery can be accomplished by encapsulating mRNAs of interest within optimized poly(amine-co-ester) polyplexes [nanoparticles].

Polyplex-delivered mRNAs were efficiently translated into protein in the lungs of mice with limited evidence of toxicity. This platform was successfully applied as an intranasal SARS-CoV-2 vaccine, eliciting robust immune responses that conferred protection against subsequent viral challenge. These results highlight the potential of this delivery system for vaccine applications and beyond.

The team, led by cellular and molecular physiologist Mark Saltzman, explained that the inhalable mRNA vaccine... Subscribe for free to Breaking Christian News here

Continue reading Here.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

AMERICAN SOUNDTRACK: Singer-Songwriter Kaylin Roberson Honors Father and 250 Years of Brave Soldiers in Stirring Ballad 'So I Didn't Have To' (Video)

America of 1976 Would Not Recognize Herself in Our 250th Year

Baseball Players Refuse to Wear Pride Uniforms, Forced to Forfeit

Canada: Carney Liberals Move to 'Force' Radical Internet Surveillance Bill through House

Belfast Is Burning, and the Media Won't Say Why

Israel, Hezbollah Agree to New Ceasefire after Conflict Delayed US-Iran Talks

Report: Biden-Era FDA Spun Autopsy Results to Downplay COVID Vaccine Deaths in Kids, Letter Shows

Newly Exposed: Fauci Funded Wuhan Lab Research That Sparked COVID; Evidence Fauci Manipulated Intelligence and Lied to Congress

From Pulisic's 'Bible Time' to Team Prayer on the Field, US Gives 'Glory to God' at World Cup

Good News: Gasoline Drops Below $4 A Gallon

Pennsylvania Governor Shapiro Abandoning 30,000 Children as Democrats Push to Strip School Choice

Canada's Parliament Officially Passes 'Bible Ban' Bill C-9

Occupied Britain: Muslim Rape Gang Report Warns against Dangers of Mass Immigration (Part 1)

Obama Center Contractors Say Millions Are Owed

VP Vance Defends Iran Deal, Says It Will Benefit Both America and Israel

President Trump Signs MOU with Iran During Dinner at Palace of Versailles (VIDEO)

[Watch] JD Vance Ventures Onto 'The View,' Serves Up an Unforgettable Schooling

School District Pays $95K to Settle Lawsuit After Painting Over Bible Verse Tribute to Charlie Kirk

Is MLB Treating Christians Differently? Senator Hawley Demands Answers

Hundreds of Thousands of Antidepressants Recalled Over Potential Cancer Risk